- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| home:patients:cohort_statistics [03.12.2019] – [Later information 2013] sallieq | home:patients:cohort_statistics [09.14.2022] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 4: | Line 4: | ||
| ====== Statistics on the Marshall Protocol | ====== Statistics on the Marshall Protocol | ||
| - | The primary function of the Marshall Protocol (MP) study site is to learn how the MP affects and improves the health of patients with a variety of inflammatory conditions. As of February 2009, there are about 1,000 patients who post in their progress reports on the MP study site. Many patients have recovered sufficiently to rejoin the work force, and subsequently become so busy that they no longer report progress. Autoimmunity Research Foundation is currently in the process of partnering with a hospital which has the resources necessary to manage a large-scale cohort study of the MP. | + | The primary function of the Marshall Protocol (MP) study site is to learn how the MP affects and improves the health of patients with a variety of inflammatory conditions. As of February 2009, there are about 1,000 patients who post in their progress reports on the MP study site. Most patients have recovered sufficiently to rejoin the work force, and subsequently become so busy that they no longer report progress. Autoimmunity Research Foundation is currently in the process of partnering with a hospital which has the resources necessary to manage a large-scale cohort study of the MP. |
| ===== Response rate ===== | ===== Response rate ===== | ||
| Line 14: | Line 14: | ||
| The best data collected thus far (//as at 2010//) is from a 2008 survey of MP patients with autoimmune diseases, the methodology of which is [[home: | The best data collected thus far (//as at 2010//) is from a 2008 survey of MP patients with autoimmune diseases, the methodology of which is [[home: | ||
| - | ARF is currently in the process of partnering with a hospital which has the resources necessary to manage a large-scale cohort study of the MP. | ||
| ==== Later information 2013 ==== | ==== Later information 2013 ==== | ||
| - | //from DJ in California.// | + | //from DJ in California// |
| < | < | ||
| Line 97: | Line 96: | ||
| {{tag> resource}} | {{tag> resource}} | ||
| + | < | ||
| ===== Notes and comments ===== | ===== Notes and comments ===== | ||
| Line 102: | Line 102: | ||
| * Legacy content | * Legacy content | ||
| - | * http:// | + | * https:// |
| - | * http:// | + | * https:// |
| - | + | </ | |
home/patients/cohort_statistics.1552432837.txt.gz · Last modified: 03.12.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.